NCT02001779

Brief Summary

Stenting the malignant biliary obstruction is considered to be the preferred palliation modality to relieve pruritus,cholangitis,pain and jaundice in patients without surgical indications of malignant biliary obstruction.An unicentral clinical trial has demonstrated the safety and technical feasibility of an irradiation biliary stent insertion in patients with biliary obstruction caused by adenocarcinomas, such a treatment seems have benefits in relieving jaundice and extending survival when compared to a conventional biliary stent.However,the small sample size,the population distribution of two groups will influence the final results in obtaining a powerful statistical conclusion.Therefore,a multicentric study was designed to prospectively compared the responses to the treatment with this irradiation biliary stent versus the conventional biliary self-expandable stent in patients with inoperable malignant biliary obstruction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
328

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2013

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 5, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

February 14, 2017

Status Verified

February 1, 2017

Enrollment Period

2.9 years

First QC Date

November 22, 2013

Last Update Submit

February 12, 2017

Conditions

Keywords

Malignant biliary obstructionObstruction/strictureStentBrachytherapyBile duct

Outcome Measures

Primary Outcomes (1)

  • Patency

    Time from stenting to the day when stricture/obstruction of the stent occured or restricture/reobstruction after recanalization the obstructed stent.

    Participants will be followed till die or lost to follow-up,an expected average of a year.

Secondary Outcomes (3)

  • Over survival

    Participants will be followed till die or lost to follow-up,an expected average of a year.

  • Clinical success

    Participants will be followed till die or lost to follow-up,an expected average of a year.

  • Safety

    Participants will be followed till die or lost to follow-up,an expected average of a year.

Study Arms (2)

Biliary SEMS loaded with 125I seeds

EXPERIMENTAL

A self-expandable metallic biliary stent loaded with 125 iodine seeds is inserted in patients with inoperable malignant biliary obstruction.

Device: Biliary SEMS loaded with 125I seeds

Conventional biliary SEMS

ACTIVE COMPARATOR

A self-expandable metallic biliary stent is inserted in patients with inoperable malignant biliary obstruction.

Device: Conventional biliary SEMS

Interventions

A self-expandable metallic biliary stent loaded with 125 iodine seeds is inserted in patients with inoperable malignant biliary obstruction.

Biliary SEMS loaded with 125I seeds

A self-expandable metallic stent is inserted in patients with inoperable malignant biliary obstruction.

Conventional biliary SEMS

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical,histological or pathological diagnosis of malignant biliary obstruction
  • Unresectability or refusal to be surgically treated
  • The Eastern Cooperative Oncology Group(ECOG) scores from 0 to 3
  • With symptoms such as jaundice related to biliary obstruction
  • Willing and able to comply with the study procedures and provide written informed consent to participate in the study
  • Biliary obstruction of Bismuthe-Corlette,type I and II

You may not qualify if:

  • Benign biliary obstruction
  • The Eastern Cooperative Oncology Group(ECOG) score of 4
  • Biliary tract stricture that could not be dilated enough to pass the delivery system
  • Presence of metallic biliary stent or bile duct surgery
  • Percutaneous transhepatic cholangiography(PTC) procedure was contraindicated
  • Active hepatitis
  • Biliary obstruction of Bismuthe-Corlette,type Ⅲ and Ⅳ
  • Uncooperative or could not provide authorization and signature

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongda Hospital,Southeast University

Nanjing, Jiangsu, 210009, China

Location

Related Publications (1)

  • Zhu HD, Guo JH, Huang M, Ji JS, Xu H, Lu J, Li HL, Wang WH, Li YL, Ni CF, Shi HB, Xiao EH, Lv WF, Sun JH, Xu K, Han GH, Du LA, Ren WX, Li MQ, Mao AW, Xiang H, Zhang KX, Min J, Zhu GY, Su C, Chen L, Teng GJ. Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial. J Hepatol. 2018 May;68(5):970-977. doi: 10.1016/j.jhep.2017.12.028. Epub 2018 Jan 10.

MeSH Terms

Conditions

Bites and StingsConstriction, Pathologic

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and InjuriesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Gao-jun Teng, Ph.D,MD

    Zhongda Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Radiology & Chair,Department of Radiology

Study Record Dates

First Submitted

November 22, 2013

First Posted

December 5, 2013

Study Start

October 1, 2013

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

February 14, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Locations